Hamlet BioPharma AB

Urologic Oncology

Research activity is centered on non-muscle invasive bladder cancer, with attention to patients awaiting transurethral surgery for tumour removal.

  • Bladder cancer
  • Non-muscle invasive disease
  • Preoperative treatment

The clinical focus includes therapeutic options intended for local management of bladder tumours before surgery.

Intravesical Therapy

Clinical interest includes intravesical instillation approaches designed to deliver treatment directly into the urinary bladder.

  • Local bladder delivery
  • Topical oncologic treatment
  • Bladder-preserving strategies

The sponsor’s research activity reflects a therapeutic emphasis on localized intervention within the bladder cavity.

Oncology Drug Evaluation

The funded trial examines the safety and efficacy of a candidate treatment in adult patients with bladder cancer.

  • Anticancer therapy assessment
  • Adult oncology
  • Comparative treatment evaluation

Research interest extends to clinical assessment of a novel therapeutic option against placebo in a bladder cancer setting.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Effectiveness of Alpha1H for Adults with Non-Muscle Invasive Bladder Cancer Awaiting Tumor Removal Surgery

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    Czechia